A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)

Clinical trial NCT05058040 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05058040
Sponsor: Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2021-06-02
Primary completion: 2025-01-01
Enrollment: 2500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.